Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 2 of 2 entries
View as:
Phase: N/A
Priority: Normal
Start: 02/28/15
End: 10/31/15
Due: 10/31/16
Phase: N/A
Priority: Normal
Start: 09/30/14
End: 12/31/14
Due: 12/31/15
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Study Evaluating Safety, Tolerability, and PK of Multiple Ascending Doses of GC021109 in Subjects With Mild to Moderate Alzheimer's Disease | NCT02386306 | GliaCure, Inc. | user2@example.com | None | 2015-02-28 | 2015-10-31 | 2016-10-31 | - | - | 2025-07-14 |
| Safety, Tolerability, and Pharmacokinetic Study of Single Ascending Doses of GC021109 in Healthy Subjects | NCT02254369 | GliaCure, Inc. | user2@example.com | None | 2014-09-30 | 2014-12-31 | 2015-12-31 | - | - | 2025-07-14 |